Showing 40,421 - 40,440 results of 63,782 for search '(( 09 ((0 decrease) OR (a decrease)) ) OR ( 20 ((we decrease) OR (mean decrease)) ))', query time: 1.59s Refine Results
  1. 40421
  2. 40422
  3. 40423
  4. 40424

    DataSheet_2_Intracellular trafficking of fatty acids in the fish intestinal epithelial cell line RTgutGC.pdf by Chandrasekar Selvam (13879730)

    Published 2022
    “…To investigate this topic, we used the rainbow trout intestinal epithelial cell line (RTgutGC) as an in vitro model. …”
  5. 40425

    Multiple endophenotypes exhibited by <i>bbs</i> mutants. by Calvin A. Mok (201207)

    Published 2011
    “…ANOVA with Tukey, *** p<0.001, n≥20. Data represent mean ± SD normalized against wild-type body length. …”
  6. 40426
  7. 40427
  8. 40428

    Selective expansion of peritoneal cavity B1a cells in mice with targeted mutation of the <i>Siglecg</i> gene. by Cheng Ding (34937)

    Published 2007
    “…Serum concentration of different isotypes of Ig, note substantial increase of IgM and decrease of IgG1 in the mutant mice. Data shown in the lower panels are Means+SEM, with 20 mice per group. …”
  9. 40429

    Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-co... by Tadao Akizawa (316095)

    Published 2018
    “…</p><p>Results</p><p>In total, 152 HDSHPT were randomized. The mean ± standard deviation (median, interquartile range) of percent changes in iPTH from baseline to end of treatment were −8.40±25.43% (−12.16, 39.60), −10.56±22.86% (−14.24, 27.85), and −20.16±34.23% (−23.83, 39.05) in the evocalcet 0.5, 1, and 2 mg/day groups and 5.44±25.85% (3.52, 35.39) and −25.86±27.76% (−29.79, 34.15) in the placebo and cinacalcet groups, respectively. …”
  10. 40430

    <b>Tirzepatide Associated with Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Cli... by Ellen M. Apperloo (20405468)

    Published 2025
    “…</p><p dir="ltr"><i>Results:</i> The adjusted (95% CI) mean percent change from baseline in UACR for tirzepatide 5, 10, or 15 mg compared with all pooled comparators was -19.3% (-25.5, -12.5), -22.0% (-28.1, -15.3) and -26.3 (-32.0, -20.0), respectively, at Week 40/42. …”
  11. 40431

    Image_2_Effect of metformin on sepsis-associated acute lung injury and gut microbiota in aged rats with sepsis.tif by Youdong Wan (14766238)

    Published 2023
    “…We collected feces from rats and analyzed them by 16S rRNA sequencing. …”
  12. 40432

    Image_1_Effect of metformin on sepsis-associated acute lung injury and gut microbiota in aged rats with sepsis.tif by Youdong Wan (14766238)

    Published 2023
    “…We collected feces from rats and analyzed them by 16S rRNA sequencing. …”
  13. 40433

    Metformin does not further increase the median lifespan of DR-constitutive mutant eat-2, and metformin treatment triggers several DR phenotypes in wild-type <i>C. elegans</i> witho... by Brian Onken (86790)

    Published 2010
    “…</b> Age pigment fluorescence measurements in wild-type animals raised on 0 mM, 1 mM, 10 mM, and 50 mM metformin plates. We found that age pigment fluorescence decreases with increasing metformin concentration with the levels in the 50 mM group significantly lower than the controls (<i>P</i> = 0.0270 by an unpaired t test). …”
  14. 40434

    Co-localization between placental CS and SDC1 in third-trimester placental tissue. by Marina Ayres Pereira (3073296)

    Published 2016
    “…Scale bar represents 20 μm. (M) Addition of soluble CSA (sCSA) does not decrease the detection of SDC1 with CS chains (detected with an α-CS-56 antibody) in the placental tissue perfused with VAR2CSA-expressing parasites. …”
  15. 40435
  16. 40436

    Table_1_Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials.pdf by Osamu Ezaki (219242)

    Published 2023
    “…</p>Results<p>MCT supplementation for 3 months increased muscle function relative to LCT supplementation with and without an L-leucine (1.2 g) and vitamin D (cholecalciferol, 20 μg)-enriched supplement. In a combined data analysis (n = 29 in MCTs, n = 27 in LCTs), relative to supplementation with 6 g LCTs/day, supplementation with 6 g MCTs/day at dinner for 3 months significantly increased body weight (adjusted mean change from baseline: MCTs 1.2 vs. …”
  17. 40437

    Table_2_Medium-chain triglycerides (8:0 and 10:0) increase muscle mass and function in frail older adults: a combined data analysis of clinical trials.pdf by Osamu Ezaki (219242)

    Published 2023
    “…</p>Results<p>MCT supplementation for 3 months increased muscle function relative to LCT supplementation with and without an L-leucine (1.2 g) and vitamin D (cholecalciferol, 20 μg)-enriched supplement. In a combined data analysis (n = 29 in MCTs, n = 27 in LCTs), relative to supplementation with 6 g LCTs/day, supplementation with 6 g MCTs/day at dinner for 3 months significantly increased body weight (adjusted mean change from baseline: MCTs 1.2 vs. …”
  18. 40438

    Cooling of porcine semen in an extender supplemented with isoespintanol by Giovanni Restrepo Betancur (15475582)

    Published 2023
    “…Regression analysis and comparison of means using the Duncan test were performed. The ISO added had a slight impact on sperm motility, as evidenced by a reduction in TM at 24 h of cooling (but not prior) with the addition of 20 µM of ISO. …”
  19. 40439

    Table_1_Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men.docx by Renata Esposito (7420730)

    Published 2019
    “…Interestingly, MS + ICS-treated women had significantly lower levels of blood eosinophils (from 5.27 ± 0.30 to 3.30 ± 0.31; p < 0.0449) and exhaled nitric oxide (from 44.70 ± 7.30 to 25.20 ± 3.90; p < 0.0294) compared with men.</p><p>Conclusion: The treatment with MS, added to ICS, in women leads to better control of symptoms, better management of lung function, and decreased inflammation levels compared with ICS + MS treatment in men.…”
  20. 40440

    Channel Network Control on Seasonal Lake Area Dynamics in Arctic Deltas by Tejedor, Alejandro

    Published 2020
    “…We find that monthly shrinkage rates have a pronounced structured variability around the channel network with the shrinkage rate systematically decreasing farther away from the channels. …”
    Get full text